FIELD: chemistry.
SUBSTANCE: for producing said salt, 2-ethyl-6-methyl-3-hydroxypyridine is dissolved in isopropyl alcohol at room temperature with stirring. Salicylic acid is dissolved in isopropyl alcohol at room temperature with stirring. Further, equal amounts of the solutions described above are mixed. Resulting mixture is cooled to 5 °C and maintained until the solvent is evaporated and precipitation in the form of a glassy mass settles out. Precipitate is maintained at a temperature of 5 °C for four days before formation of the crystals. Resulting salt is a white crystalline powder. Salt has a peak of 98–104 °C according to the differential scanning calorimetry measurements and peaks 20Θ° 7.5, 11.2, 14.0, 15.0, 16.3, 17.1, 19.5, 21.1, 22.6, 24.3, 25.4, 27.7, 32.6 according to measurements of X-ray diffraction of a polycrystal.
EFFECT: salicylate salt of 2-ethyl-6-methyl-3-hydroxypyridine and a method for producing thereof; also its solvates and hydrates.
14 cl, 8 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE OROTATE DIHYDRATE AND METHOD FOR PRODUCTION THEREOF | 2017 |
|
RU2690674C2 |
NOVEL 3-HYDROXYPYRIDINE DERIVATIVE HAVING LIPID REGULATING ACTIVITY | 2020 |
|
RU2743923C1 |
SYNERGETIC PREPARATION FOR TREATING CARDIOVASCULAR DISEASES, DIABETES MELLITUS AND HEPATOBILIARY DISEASES | 2012 |
|
RU2493841C1 |
PHARMACEUTICAL NEUROPROTECTIVE, ANTIOXIDANT, ANTIHYPOXIC, ANTIAPOPTOTIC AND MEMBRANE PROTECTIVE COMPOSITION AND METHOD OF TREATMENT | 2008 |
|
RU2385722C1 |
USE OF A PHARMACEUTICAL COMPOSITION WITH ANTIOXIDANT, VIRUCIDAL, IMMUNOSTULATING, ANTIHYPOXIC AND ANTI-AGGREGANT EFFECT | 2023 |
|
RU2808445C1 |
MEDICINAL AGENT FOR PREVENTING AND TREATING CEREBRAL DISEASES AND METHOD OF TREATING CEREBRAL DISEASES | 2015 |
|
RU2692063C2 |
ASPIRINATE-2-ETHYL-6-METHYL-3-HYDROXIPIRIDINE THAT IS ANTOHYPOXIC AND WAY OF ITS PRODUCTION | 2010 |
|
RU2442774C1 |
METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE AND CHRONIC BRAIN ISCHEMIA | 2021 |
|
RU2752065C1 |
NEUROTROPIC PREPARATION, POSSESSING ANTI-HYPOXIC, NEUROPROTECTIVE, ANTI-AMNESTIC AND VESTIBULAR-PROTECTIVE ACTIVITY | 2014 |
|
RU2547728C1 |
DOSAGE FORM FOR INJECTION IN FORM OF SOLUTION AND STABILIZER FOR ITS PREPARATION | 2020 |
|
RU2755094C1 |
Authors
Dates
2018-05-03—Published
2017-03-16—Filed